Long-lasting effects of a single subcutaneous dose of ketamine for treating melancholic depression: a case report

Affiliations

¹ School of Psychiatry, University of New South Wales, Black Dog Institute.
² Department of Anaesthesia and Pain Management, Royal North Shore Hospital, St. Leonards.
³ School of Medicine, University of New South Wales.
⁴ Psychological Medicine, University of Otago, Dunedin, New Zealand.
⁵ Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, Australia.
⁶ Wesley Hospital, Kogarah, Sydney.
⁷ School of Psychiatry, University of New South Wales, Black Dog Institute. Electronic address: colleen.loo@unsw.edu.au.

Comment

Veronica Gálvez et al. Biol Psychiatry. 2014.

. 2014 Aug 1;76(3):e1-2.

doi: 10.1016/j.biopsych.2013.12.010. Epub 2014 Jan 3.

¹ School of Psychiatry, University of New South Wales, Black Dog Institute.
² Department of Anaesthesia and Pain Management, Royal North Shore Hospital, St. Leonards.
³ School of Medicine, University of New South Wales.
⁴ Psychological Medicine, University of Otago, Dunedin, New Zealand.
⁵ Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, Australia.
⁶ Wesley Hospital, Kogarah, Sydney.
⁷ School of Psychiatry, University of New South Wales, Black Dog Institute. Electronic address: colleen.loo@unsw.edu.au.

No abstract available

Comment on

Antidepressant effects of ketamine in depressed patients.
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Berman RM, et al. Biol Psychiatry. 2000 Feb 15;47(4):351-4. doi: 10.1016/s0006-3223(99)00230-9. Biol Psychiatry. 2000. PMID: 10686270 Clinical Trial.